The 35% CO 2 Hyperreactivity and Clinical Symptomatology in Patients With Panic Disorder After 1 Week of Treatment With Citalopram: An Open Study
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The effect of a short treatment (7 days) with citalopram on the reactivity to inhalations of 35% CO2 and 65% oxygen and on clinical symptomatology was investigated in 15 patients with panic disorder who had a positive response to 35% CO2 inhalation. An open study design was applied. On day 0, before starting drug treatment, and after 1 week of treatment, each patient underwent the 35% CO2 challenge, and clinical symptomatology was evaluated with psychometric scales. The results showed a significant reduction of CO2 reactivity and of scores on the anticipatory anxiety subscale of Panic Associated Symptoms Scale. These results confirm that the serotonergic system plays an important role in the modulation of CO2 hyperreactivity and suggest an early anxiolytic effect of citalopram in patients who have panic disorder and are hyperreactive to CO2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801
False Suffocation Alarms, Spontaneous Panics, and Related Conditions: An Integrative Hypothesis
Klein, D. F. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820160076009 · Cited by 1,130
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492
Ventilatory physiology of patients with panic disorder
Gorman, J. M. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250035006 · Cited by 354
Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study
Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K., & Manniche, P. M. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.3.374 · Cited by 261
An Open Trial of Fluoxetine in the Treatment of Panic Attacks
GORMAN, J. M., LIEBOWITZ, M. R., FYER, A. J., GOETZ, D., CAMPEAS, R. B., FYER, M. R., DAVIES, S. O., & KLEIN, D. F. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198710000-00007 · Cited by 175
Carbon dioxide/oxygen challenge test in panic disorder
Perna, G., Battaglia, M., Garberi, A., Arancio, C., Bertani, A., & Bellodi, L. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90085-x · Cited by 142
Self-citation
Cited by
Panic disorder and control of breathing
Nardi, A. E., Freire, R. C., & Zin, W. A. (2009) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2008.07.011 · Cited by 151
Risks and benefits of medications for panic disorder: A comparison of SSRIs and benzodiazepines
Quagliato, L. A., Freire, R. C., & Nardi, A. E. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1429403 · Cited by 62
Antipanic Drug Modulation Of 35% CO2 Hyperreactivity and Short-Term Treatment Outcome
Perna, G., Bertani, A., Caldirola, D., Gabriele, A., Cocchi, S., & Bellodi, L. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00011 · Cited by 48
Self-citationGorman, J. M., Martinez, J., Coplan, J. D., Kent, J., & Kleber, M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.016 · Cited by 42
Perna, G., Bertani, A., Caldirola, D., Di Pasquale, D., Migliarese, G., & Bellodi, L. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125682.97466.3c · Cited by 37
Self-citation
Metadata
- Authors
- Bertani, A., Caldirola, D., Bussi, R., Bellodi, L., & Perna, G.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2001-06
- Volume
- 21
- Issue
- 3
- Pages
- 262-267
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2321195624
- Cited by
- 32
- References
- 7
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The 35% CO 2 Hyperreactivity and Clinical Symptomatology in Patients With Panic Disorder After 1 Week of Treatment With Citalopram: An Open Study. https://app.cochat.ai/papers/10.1097/00004714-200106000-00003
- The paper
- Bertani, A., Caldirola, D., Bussi, R., Bellodi, L., & Perna, G. (2001). The 35% CO 2 Hyperreactivity and Clinical Symptomatology in Patients With Panic Disorder After 1 Week of Treatment With Citalopram: An Open Study. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-200106000-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.